← 返回

巨噬细胞串扰与治疗:肿瘤细胞与免疫细胞之间

英文原题:Macrophage crosstalk and therapies: Between tumor cells and immune cells.

查看英文原题

Macrophage crosstalk and therapies: Between tumor cells and immune cells.

PubMed 2024/08/30(内容时间) Int Immunopharmacol Q1 · IF 5.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

在肿瘤微环境中,巨噬细胞响应各种信号表现出不同的表型和功能,在肿瘤的发生和进展中起着至关重要的作用。多项研究表明,干预不同表型的肿瘤相关巨噬细胞的功能,会显著改变肿瘤细胞与免疫相关细胞(如 T、NK 和 B 细胞)之间的 crosstalk,从而明显改变肿瘤发展的进程。然而,目前仅有少数针对巨噬细胞的特定治疗策略可用。本文全面综述了肿瘤相关巨噬细胞介导肿瘤细胞与免疫相关细胞之间 crosstalk 的分子生物学机制。同时,总结了目前临床实践中使用的以及处于临床试验阶段的各种治疗方法,并据此对靶向肿瘤相关巨噬细胞的新策略进行了分类。

展开英文摘要原文

In the tumor microenvironment, macrophages exhibit different phenotypes and functions in response to various signals, playing a crucial role in the initiation and progression of tumors. Several studies have indicated that intervention in the functions of different phenotypes of tumor-associated macrophages causes significant changes in the crosstalk between tumor cells and immune-related cells, such as T, NK, and B cells, markedly altering the course of tumor development.

However, only a few specific therapeutic strategies targeting macrophages are yet available. This article comprehensively reviews the molecular biology mechanisms through which tumor-associated macrophages mediate the crosstalk between tumor cells and immune-related cells. Also, various treatment methods currently used in clinical practice and those in the clinical trial phase have been summarized, and the novel strategies for targeting tumor-associated macrophages have been categorized accordingly.

论文信息

作者
Fan CY、Zheng JS、Hong LL、Ling ZQ
第一作者单位
Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310018, China; The Second School of Clinical Medicine, Wenzhou Medical University, No.109 Xueyuan West Road, Wenzhou, 325027 Zhejiang, China.China
通讯作者单位
Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310018, China. Electronic address: lingzq@zjcc.org.cn.China
文献类型
综述
期刊
International immunopharmacology2024 Nov 15
原文标识
PubMed 39213868 · DOI 10.1016/j.intimp.2024.113037